Brought to you by 
Corvas, Vascular Genomics collaborate on proteomics
13 Jul 1999
Executive Summary
Cardiovascular biotech Corvas International will collaborate with Vascular Genomics on the development of a map of the body's endothelial proteins, with a three-year option to acquire the company.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com